Canada Markets close in 5 hrs 57 mins

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.35-0.38 (-3.54%)
As of 04:00PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 337.99
52 Week Low 39.39
50-Day Moving Average 312.81
200-Day Moving Average 319.12

Share Statistics

Avg Vol (3 month) 376.88k
Avg Vol (10 day) 388k
Shares Outstanding 541.61M
Implied Shares Outstanding 6N/A
Float 811.77M
% Held by Insiders 111.01%
% Held by Institutions 196.76%
Shares Short (Apr 28, 2022) 42.82M
Short Ratio (Apr 28, 2022) 448.29
Short % of Float (Apr 28, 2022) 418.55%
Short % of Shares Outstanding (Apr 28, 2022) 46.78%
Shares Short (prior month Mar 30, 2022) 43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-905.39%

Management Effectiveness

Return on Assets (ttm)-10.39%
Return on Equity (ttm)-17.50%

Income Statement

Revenue (ttm)3.64M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-22.6M
EBITDA -32.82M
Net Income Avi to Common (ttm)-32.67M
Diluted EPS (ttm)-1.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)374.96M
Total Cash Per Share (mrq)9.09
Total Debt (mrq)194k
Total Debt/Equity (mrq)0.05
Current Ratio (mrq)29.46
Book Value Per Share (mrq)9.05

Cash Flow Statement

Operating Cash Flow (ttm)-16.98M
Levered Free Cash Flow (ttm)577.38k